Orphan Drugs Market Size And Share

  • Report Code : TIPRE00005799
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

孤儿药市场规模、份额及预测(2025-2031)

Buy Now

Orphan Drugs Market Report Analysis

Orphan Drugs Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • F. Hoffmann-La Roche Ltd
  • Eli Lilly and Company
  • Alexion
  • CELGENE CORPORATION
  • Novartis AG
  • Takeda Pharmaceuticals Company Limited
  • Biogen
  • Bristol-Myers Squibb Company
  • Bayer AG

Regional Overview

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

Market Segmentation

By 活性成分
  • Obinutuzumab
  • 来那度胺
  • Brentuximab
  • Vedotin
  • 利奥西呱
  • 奥法木单抗
  • 奈拉滨
  • 博舒替尼
  • 甘露醇
  • 卡格鲁酸
  • 氨曲南
  • 盐酸组胺
  • 依利鲁司他
  • 卡博替尼
  • 雷莫芦单抗
  • 地西他滨
  • 去纤苷
By 疾病[霍奇金淋巴瘤, 阵发性睡眠性血红蛋白尿, 慢性血栓栓塞性肺动脉高压
  • CTEPH
  • 慢性淋巴细胞白血病
  • 慢性粒细胞白血病
  • T 细胞急性淋巴细胞白血病
By 最终用户
  • 医院
  • 门诊手术中心
By 地理
  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲